GAMMA Investing’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$43.6K Buy
1,226
+41
+3% +$1.62K ﹤0.01% 2457
2026
Q2
$55K Buy
1,185
+141
+14% +$5.07K ﹤0.01% 2235
2026
Q1
$25.6K Sell
1,044
-429
-29% -$10.2K ﹤0.01% 2588
2025
Q4
$36.5K Buy
1,473
+871
+145% +$23.1K ﹤0.01% 2279
2025
Q3
$17.1K Sell
602
-51
-8% -$1.38K ﹤0.01% 2600
2025
Q2
$16.2K Buy
653
+250
+62% +$7.04K ﹤0.01% 2566
2025
Q1
$12.5K Buy
403
+191
+90% +$6.36K ﹤0.01% 2633
2024
Q4
$6.68K Sell
212
-368
-63% -$17.5K ﹤0.01% 2788
2024
Q3
$33.6K Buy
580
+264
+84% +$13K ﹤0.01% 1766
2024
Q2
$12.8K Buy
316
+26
+9% +$1.03K ﹤0.01% 2106
2024
Q1
$12.2K Sell
290
-218
-43% -$8.5K ﹤0.01% 1949
2023
Q4
$17.7K Buy
+508
New +$16.9K ﹤0.01% 1584

Other funds holding ASTH

GAMMA Investing's ASTH Position: Q3 2026 in Review

GAMMA Investing increased its Astrana Health (ASTH) stake by 3.5% in Q3 2026, buying an estimated $1.62K and bringing the position to 1,226 shares worth $43.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2457.

GAMMA Investing first reported a position in ASTH in Q4 2023 and has held it in 12 quarters since. The position peaked at $55K in Q2 2026. 11 funds tracked by Wall St. Rank hold ASTH as of Q3 2026.

  • GAMMA Investing held 1,226 shares of Astrana Health worth $43.6K as of Q3 2026.
  • GAMMA Investing bought 41 Astrana Health shares in Q3 2026, an estimated $1.62K.
  • Astrana Health made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #2457 holding.
  • GAMMA Investing first reported a position in Astrana Health in Q4 2023 and has held it in 12 quarters since.
  • GAMMA Investing's Astrana Health position peaked at $55K in Q2 2026.
  • 11 funds tracked by Wall St. Rank held Astrana Health as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.